211 related articles for article (PubMed ID: 20734161)
1. Raf-1 kinase inhibitory protein expression in thyroid carcinomas.
Kim HS; Kim GY; Lim SJ; Kim YW
Endocr Pathol; 2010 Dec; 21(4):253-7. PubMed ID: 20734161
[TBL] [Abstract][Full Text] [Related]
2. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
3. Fibrillin expression and localization in various types of carcinomas of the thyroid gland.
Tseleni-Balafouta S; Gakiopoulou H; Fanourakis G; Voutsinas G; Litsiou H; Sozopoulos E; Balafoutas D; Patsouris E
Mod Pathol; 2006 May; 19(5):695-700. PubMed ID: 16528372
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
6. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
7. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.
Buehler D; Hardin H; Shan W; Montemayor-Garcia C; Rush PS; Asioli S; Chen H; Lloyd RV
Mod Pathol; 2013 Jan; 26(1):54-61. PubMed ID: 22899291
[TBL] [Abstract][Full Text] [Related]
8. Iodine deficiency and thyroid nodular pathology--epidemiological and cancer characteristics in different populations: Portugal and South Africa.
Santos JE; Kalk WJ; Freitas M; Marques Carreira I; Castelo Branco M
BMC Res Notes; 2015 Jul; 8():284. PubMed ID: 26126625
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.
Moretti S; Menicali E; Voce P; Morelli S; Cantarelli S; Sponziello M; Colella R; Fallarino F; Orabona C; Alunno A; de Biase D; Bini V; Mameli MG; Filetti S; Gerli R; Macchiarulo A; Melillo RM; Tallini G; Santoro M; Puccetti P; Avenia N; Puxeddu E
J Clin Endocrinol Metab; 2014 May; 99(5):E832-40. PubMed ID: 24517146
[TBL] [Abstract][Full Text] [Related]
10. Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid.
Arai T; Yamashita T; Urano T; Masunaga A; Itoyama S; Itoh K; Shiku H; Sugawara I
Mod Pathol; 1995 Apr; 8(3):252-6. PubMed ID: 7617649
[TBL] [Abstract][Full Text] [Related]
11. Ectopic expression of bone sialoprotein in human thyroid cancer.
Bellahcène A; Albert V; Pollina L; Basolo F; Fisher LW; Castronovo V
Thyroid; 1998 Aug; 8(8):637-41. PubMed ID: 9737356
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation signatures identify biologically distinct thyroid cancer subtypes.
Rodríguez-Rodero S; Fernández AF; Fernández-Morera JL; Castro-Santos P; Bayon GF; Ferrero C; Urdinguio RG; Gonzalez-Marquez R; Suarez C; Fernández-Vega I; Fresno Forcelledo MF; Martínez-Camblor P; Mancikova V; Castelblanco E; Perez M; Marrón PI; Mendiola M; Hardisson D; Santisteban P; Riesco-Eizaguirre G; Matías-Guiu X; Carnero A; Robledo M; Delgado-Álvarez E; Menéndez-Torre E; Fraga MF
J Clin Endocrinol Metab; 2013 Jul; 98(7):2811-21. PubMed ID: 23666970
[TBL] [Abstract][Full Text] [Related]
13. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P
Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205
[TBL] [Abstract][Full Text] [Related]
14. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories.
Tallini G; Garcia-Rostan G; Herrero A; Zelterman D; Viale G; Bosari S; Carcangiu ML
Am J Surg Pathol; 1999 Jun; 23(6):678-85. PubMed ID: 10366150
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of E-cadherin expression in thyroid neoplasms.
Naito A; Iwase H; Kuzushima T; Nakamura T; Kobayashi S
J Surg Oncol; 2001 Mar; 76(3):176-80. PubMed ID: 11276021
[TBL] [Abstract][Full Text] [Related]
17. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
[TBL] [Abstract][Full Text] [Related]
18. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma.
Miettinen M; Franssila KO
Hum Pathol; 2000 Sep; 31(9):1139-45. PubMed ID: 11014583
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive screening for PD-L1 expression in thyroid cancer.
Ahn S; Kim TH; Kim SW; Ki CS; Jang HW; Kim JS; Kim JH; Choe JH; Shin JH; Hahn SY; Oh YL; Chung JH
Endocr Relat Cancer; 2017 Feb; 24(2):97-106. PubMed ID: 28093480
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas.
Burrows N; Resch J; Cowen RL; von Wasielewski R; Hoang-Vu C; West CM; Williams KJ; Brabant G
Endocr Relat Cancer; 2010 Mar; 17(1):61-72. PubMed ID: 19808899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
